Obesity Due to Proopiomelanocortin Deficiency: Three New Cases and Treatment Trials with Thyroid Hormone and ACTH4-10

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 10, 2003, Pages 4633-4640

  Krude, Heiko ^a,e   Biebermann, Heike ^a   Schnabel, Dirk ^a   Tansek, Mojca Zerjav ^b   Theunissen, Pierre ^c   Mullis, Primus E ^d   Grüters, Annette ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c Sittard Geleen Heerlen   (Netherlands)

^d UNIVERSITY OF BERN   (Switzerland)

^e HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN[4-10]; GENE PRODUCT; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 2 RECEPTOR; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; PROOPIOMELANOCORTIN; THYROID HORMONE; THYROTROPIN; UNCLASSIFIED DRUG;

ADRENAL INSUFFICIENCY; ARTICLE; BODY WEIGHT; CASE REPORT; CHILD; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; FEMALE; FRAMESHIFT MUTATION; GENE; GENE MUTATION; HAIR COLOR; HOMOZYGOSITY; HORMONE DEFICIENCY; HUMAN; MALE; OBESITY; PIGMENT DISORDER; POMC GENE; PRIORITY JOURNAL; PROOPIOMELANOCORTIN DEFICIENCY; STOP CODON; TRANSLATION INITIATION; TREATMENT OUTCOME;

ADRENOCORTICOTROPIC HORMONE; BASAL METABOLISM; BODY WEIGHT; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; GENOTYPE; HAIR COLOR; HUMANS; INFANT; INFANT, NEWBORN; OBESITY; PEPTIDE FRAGMENTS; PHENOTYPE; PRO-OPIOMELANOCORTIN; THYROID GLAND; THYROID HORMONES;

EID: 0242320429     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030502     Document Type: Article

References (50)

1. Chretien M, Benjannet S, Gossard F, Gianoulakis C, Crine P, Lis M, Seidah NG 1979 From β-lipotropin to β-endorphin and "pro-opio-melanocortin." Can J Biochem 57:1111-1121
2. Takahashi H, Teranishi Y, Nakanishi S, Numa S 1981 Isolation and structural organization of the human corticotropin-β-lipotropin precursor gene. FEBS Lett 135:97-102
3. Whitfeld PL, Seeburg PH, Shine J 1982 The human pro-opiomelanocortin gene: organization, sequence, and interspersion with repetitive DNA. DNA 1:133-143
4. Owerbach D, Rutter WJ, Roberts JL, Whitfeld P, Shine J, Seeburg PH, Shows TB 1981 The proopiocortin (adrenocorticotropin/β-lipoprotein) gene is located on chromosome 2 in humans. Somat Cell Mol Genet 7:359-369
5. Takeuchi S, Teshigawara K, Takahashi S 1999 Molecular cloning and characterization of the chicken pro-opiomelanocortin (POMC) gene. Biochim Biophys Acta 1450:452-459
6. Seidah NG, Benjannet S, Hamelin J, Mamarbachi AM, Basak A, Marcinkiewicz J, Mbikay M, Chretien M, Marcinkiewicz M 1999 The subtilisin/kexin family of precursor convertases. Emphasis on PC1, PC2/7B2, POMC and the novel enzyme SK1-1. Ann NY Acad Sci 885:57-74
7. Wikberg JE 1999 Melanocortin receptors: perspectives for novel drugs. Eur J Pharmacol 375:295-310
8. Mountjoy KG, Robbins LS, Mortrud MT, Cone RD 1992 The cloning of a family of genes that encode the melanocortin receptors. Science 257:1248-1251
9. MacNeil DJ, Howard AD, Guan X, Fong TM, Nargund RP, Bednarek MA, Goulet MT, Weinberg DH, Strack AM, Marsh DJ, Chen HY, Shen CP, Chen AS, Rosenblum CI, MacNeil T, Tota M, MacIntyre ED, Van der Ploeg LH 2002 The role of melanocortins in body weight regulation: opportunities for the treatment of obesity. Eur J Pharmacol 450:93-109
10. Clark A J, Weber A 1998 Adrenocorticotropin insensitivity syndromes. Endocr Rev 19:828-843
11. Schaffer JV, Bolognia JL 2001 The melanocortin-1 receptor: red hair and beyond. Arch Dermatol 137:1477-1485
12. Cone RD 2000 Haploinsufficiency of the melanocortin-4 receptor: part of a thrifty genotype? J Clin Invest 106:185-187
13. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Grüters A 1998 Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19:155-157
14. Yaswen L, Diehl N, Brennan MB, Hochgeschwender U 1999 Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 5:1066-1070
15. Miraglia del Giudice E, Cirillo G, Santoro N, D'Urso L, Carbone MT, Di Toro R, Perrone L 2001 Molecular screening of the proopiomelanocortin (POMC) gene in Italian obese children: report of three new mutations. Int J Obes Relat Metab Disord 25:61-67
16. Hinney A, Becker I, Heibult O, Nottebom K, Schmidt A, Ziegler A, Mayer H, Siegfried W, Blum WF, Remschmidt H, Hebebrand J 1998 Systematic mutation screening of the pro-opiomelanocortin gene: identification of several genetic variants including three different insertions, one nonsense and two missense point mutations in probands of different weight extremes. J Clin Endocrinol Metab 83:3737-3741
17. aChallis BG, Pritchard LE, Creemers JW, Delplanque J, Keogh JM, Luan J, Wareham NJ, Yeo GS, Bhattacharyya S, Froguel P, White A, Farooqi IS, O'Rahilly S 2002 A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum Mol Genet 11:1997-2004
18. Echwald SM, Sorensen TI, Andersen T, Tybjaerg-Hansen A, Clausen JO, Pedersen O 1999 Mutational analysis of the proopiomelanocortin gene in Caucasians with early onset obesity. Int J Obes Relat Metab Disord 23:293-298
19. Kim MS, Small CJ, Stanley SA, Morgan DG, Seal LJ, Kong WM, Edwards CM, Abusnana S, Sunter D, Ghatei MA, Bloom SR 2000 The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. J Clin Invest 105:1005-1011
20. Harris M, Aschkenasi C, Elias CF, Chandrankunnel A, Nillni EA, Bjoorbaek C, Elmquist JK, Flier JS, Hollenberg AN 2001 Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling. J Clin Invest 107:111-120
21. Fehm HL, Smolnik R, Kern W, McGregor GP, Bickel U, Born J 2001 The melanocortin melanocyte-stimulating hormone/adrenocorticotropin(4-10) decreases body fat in humans. J Clin Endocrinol Metab 86:1144-1148
22. Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C, Charraud A 1991 Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr 45:13-21
23. Duggan MB, Tobin G, Milner RD, Accuracy in indirect calorimetry. Proc European Nutrition Workshop on Energy Metabolism, University of Wageningen, The Netherlands, 1985, pp 113-118
24. Weir JB 1949 New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 109:1-9
25. Kaplan AS, Zemel BS, Neiswender KM, Stallings VA 1995 Resting energy expenditure in clinical pediatrics: measured versus prediction equations. J Pediatr 127:200-205
26. Kozak M 1989 The scanning model for translation: an update. J Cell Biol 108:229-241
27. Adan RA, Cone RD, Burbach JP, Gispen WH 1994 Differential effects of melanocortin peptides on neural melanocortin receptors. Mol Pharmacol 46: 1182-1190
28. Lerner AB 1993 The discovery of the melanotropins. A history of pituitary endocrinology Ann NY Acad Sci 680:1-12
29. De Wied D, Jolles J 1982 Neuropeptides derived from pro-opiocortin: behavioral, physiological, and neurochemical effects. Physiol Rev 62:976-1059
30. Gantz I, Konda Y, Tashiro T, Shimoto Y, Miwa H, Munzert G, Watson SJ, DelValle J, Yamada T 1993 Molecular cloning of a novel melanocortin receptor. J Biol Chem 268:8246-8250
31. Gantz I, Miwa H, Konda Y, Shimoto Y, Tashiro T, Watson SJ, DelValle J, Yamada T 1993 Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem 268:15174-1519
32. Butler AA, Cone RD 2001 Knockout models resulting in the development of obesity. Trends Genet 17:50-54
33. Krude H, Grüters A 2000 Implications of proopiomelanocortin (POMC) mutations in humans: the POMC deficiency syndrome. Trends Endocrinol Metab 11:15-22
34. Ellaway CJ, Silinik M, Cowell CT, Gaskin KJ, Kamath KR, Dorney S, Donaghue KC 1995 Cholestatic jaundice and congenital hypopiruitarism. J Paediatr Child Health 31:51-53
35. Lamolet B, Pulichino AM, Lamonerie T, Gauthier Y, Brue T, Enjalbert A, Drouin J 2001 A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 104:849-859
36. Luger TA, Brzoska T, Scholzen TE, Kalden DH, Sunderkotter C, Armstrong C, Ansel J 2000 The role of alpha-MSH as a modulator of cutaneous inflammation. Ann NY Acad Sci 917:232-238
37. Barsh GS, Schwartz MW 2002 Genetic approaches to studying energy balance: perception and integration. Nat Rev Genet 3:589-600
38. Beck-Peccoz P, Amr S, Menezes-Ferreira MM, Faglia G, Weintraub BD 1985 Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. Effect of treatment with thyrotropin-releasing hormone. N Engl J Med 312:1085-1090
39. Taylor T, Gesundheit N, Gyves PW, Jacobowitz DM, Weintraub BD 1988 Hypothalamic hypothyroidism caused by lesions in rat para ventricular nuclei alters the carbohydrate structure of secreted thyrotropin. Endocrinology 122: 283-290
40. Matsumura K, Tsuchihashi T, Abe I, Iida M 2002 Central á-melanocyte-stimulating hormone acts at melanocortin-4 receptor to activate sympathetic nervous system in conscious rabbits. Brain Res 948:145-148
41. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O'Rahilly S 1999 Effects of recombinant leprin therapy in a child with congenital leptin deficiency. N Engl J Med 341:879-884
42. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, Sanna V, Jebb SA, Perna F, Fontana S, Lechler RI, DePaoli AM, O'Rahilly S 2002 Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110:1093-10103
43. De Rotte AA, Bouman HJ, van Wimersma Greidanus TB 1980 Relationships between alpha-MSH levels in blood and in cerebrospinal fluid. Brain Res Bull 5:375-381
44. Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL 2002 Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 5: 514-516
45. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD 1997 Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385:165-168
46. Wessells H, Gralnek D, Dorr R, Hruby VJ, Hadley ME, Levine N 2000 Effect of an á-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction. Urology 56:641-646
47. Van der Ploeg LH, Martin WJ, Howard AD, Nargund RP, Austin CP, Guan X, Drisko J, Cashen D, Sebhat I, Patchett AA, Figueroa DJ, DiLella AG, Connolly BM, Weinberg DH, Tan CP, Palyha OC, Pong SS, MacNeil T, Rosenblum C, Vongs A, Tang R, Yu H, Sailer AW, Fong TM, Huang C, Tota MR, Chang RS, Stearns R, Tamvakopoulos C, Christ G, Drazen DL, Spar BD, Nelson RJ, MacIntyre DE 2002 A role for the melanocortin 4 receptor in sexual function. Proc Natl Acad Sci USA 99:11381-11386
48. Konig M, Zimmer AM, Steiner H, Holmes PV, Crawley JN, Brownstein MJ, Zimmer A 1996 Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 383:535-538
49. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F 1997 Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141
50. Takahashi H, Hakamata Y, Watanabe Y, Kikuno R, Miyata T, Numa S 1983 Complete nucleotide sequence of the human corticotropin-β-lipotropin precursor gene. Nucleic Acids Res 11:6847-6858